DGS Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$517K Sell
10,737
-720
-6% -$33.6K 0.08% 227
2025
Q4
$555K Sell
11,457
-705
-6% -$34.9K 0.1% 192
2025
Q3
$574K Sell
12,162
-277
-2% -$13.4K 0.1% 174
2025
Q2
$601K Buy
12,439
+1,053
+9% +$53.8K 0.12% 155
2025
Q1
$631K Buy
11,386
+1,666
+17% +$90.2K 0.17% 130
2024
Q4
$469K Buy
9,720
+97
+1% +$4.93K 0.12% 155
2024
Q3
$555K Buy
9,623
+385
+4% +$20.8K 0.15% 142
2024
Q2
$448K Sell
9,238
-355
-4% -$17.1K 0.13% 154
2024
Q1
$466K Sell
9,593
-601
-6% -$29.3K 0.13% 140
2023
Q4
$507K Buy
10,194
+345
+4% +$16.9K 0.19% 102
2023
Q3
$528K Buy
9,849
+306
+3% +$16.3K 0.26% 89
2023
Q2
$514K Buy
9,543
+137
+1% +$7.37K 0.26% 87
2023
Q1
$512K Buy
9,406
+519
+6% +$25.2K 0.28% 80
2022
Q4
$430K Buy
8,887
+22
+0.2% +$966 0.28% 87
2022
Q3
$337K Sell
8,865
-899
-9% -$40.1K 0.23% 101
2022
Q2
$488K Buy
9,764
+1,224
+14% +$65K 0.39% 52
2022
Q1
$438K Buy
8,540
+408
+5% +$21.1K 0.27% 70
2021
Q4
$407K Buy
+8,132
New +$402K 0.25% 66

Other funds holding SNY

DGS Capital Management's SNY Position: Q1 2026 in Review

DGS Capital Management reduced its Sanofi (SNY) stake by 6.3% in Q1 2026, selling an estimated $33.6K and leaving 10,737 shares worth $517K. The position accounts for 0.08% of the portfolio, ranked #227.

DGS Capital Management first reported a position in SNY in Q4 2021 and has held it in 18 quarters since. The position peaked at $631K in Q1 2025. 744 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • DGS Capital Management held 10,737 shares of Sanofi worth $517K as of Q1 2026.
  • DGS Capital Management sold 720 Sanofi shares in Q1 2026, an estimated $33.6K.
  • Sanofi made up 0.08% of DGS Capital Management's portfolio in Q1 2026, its #227 holding.
  • DGS Capital Management first reported a position in Sanofi in Q4 2021 and has held it in 18 quarters since.
  • DGS Capital Management's Sanofi position peaked at $631K in Q1 2025.
  • 744 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.